Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
hydromorphone hydrochloride 50 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
midazolam 100 mg/100 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
human chorionic gonadotrophin 1500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
midazolam 50 mg/50 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
human chorionic gonadotrophin 5000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
brivaracetam 50 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bupivacaine hydrochloride 0.5% (50 mg/10 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
botulinum toxin type A 50 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
deoxycholic acid 20 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 3000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 1500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 1000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 750 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
efmoroctocog alfa 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alirocumab 150 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alirocumab 150 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
daclizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
daclizumab 150 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
idarucizumab 2.5 g / 50 mL injection, 50 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alirocumab 75 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alirocumab 75 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albutrepenonacog alfa 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hexaminolevulinate 85 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
omalizumab 75 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
plerixafor 24 mg/1.2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albutrepenonacog alfa 1000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albutrepenonacog alfa 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albutrepenonacog alfa 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor II 800 units + factor VII 400 units + factor IX 800 units + factor X 880 units + protein C 600 units + protein S 480 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor II 400 units + factor VII 200 units + factor IX 400 units + factor X 440 units + protein C 300 units + protein S 240 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor II 200 units + factor VII 100 units + factor IX 200 units + factor X 220 units + protein C 150 units + protein S 120 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
naloxone hydrochloride 1 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sodium ascorbate 30 g/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
etanercept 50 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
naloxone hydrochloride dihydrate 400 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
asfotase alfa 40 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
asfotase alfa 80 mg/0.8 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
asfotase alfa 12 mg/0.3 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
asfotase alfa 28 mg/0.7 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
asfotase alfa 18 mg / 0.45 mL injection, 0.45 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza quadrivalent child vaccine 2017 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza quadrivalent adult vaccine 2017 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
abatacept 125 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
chromic chloride hexahydrate 53.33 microgram/10 mL + cupric chloride dihydrate 1.02 mg/10 mL + ferric chloride hexahydrate 5.4 mg/10 mL + manganese chloride tetrahydrate 198 microgram/10 mL + potassium iodide 166 microgram/10 mL + sodium fluoride 2.1 mg/10 mL + sodium molybdate dihydrate 48.5 microgram/10 mL + sodium selenite 173 microgram/10 mL + zinc chloride 10.5 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
carfilzomib 60 mg injection, 60 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisatracurium 20 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amobarbital sodium 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefepime 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albumin human 2.5 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iopromide 312 mg (iodine 150 mg)/mL injection, 200 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
human papillomavirus bivalent vaccine injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
diphtheria 2 units + tetanus 20 units vaccine injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iopromide 312 mg (iodine 150 mg)/mL injection, 100 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor VIII 1000 units + von Willebrand factor 2400 units injection, 1 vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor VIII 250 units + von Willebrand factor 600 units injection, 1 vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor VIII 500 units + von Willebrand factor 1200 units injection, 1 vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
elotuzumab 400 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
elotuzumab 300 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amikacin 500 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bivalirudin 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcium chloride dihydrate 740 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vorhyaluronidase alfa 1600 units/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vorhyaluronidase alfa 400 units/2.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
aprotinin 2 000 000 KI units/200 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vorhyaluronidase alfa 800 units/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vorhyaluronidase alfa 2400 units/15 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vorhyaluronidase alfa 200 units/1.25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
idarubicin hydrochloride 5 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
normal immunoglobulin 30 g/300 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
aprotinin 1 000 000 KI units/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dinoprost 40 mg/8 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
naloxone hydrochloride 40 microgram/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
idarubicin hydrochloride 10 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
medroxyprogesterone acetate 150 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
glycopyrronium bromide 600 microgram/3 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
susoctocog alfa 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dinoprost 20 mg / 4 mL injection, 4 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
mivacurium 50 mg / 25 mL injection, 25 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
mivacurium 10 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 10% (1 g/10 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iopromide 769 mg (iodine 370 mg)/mL injection, 150 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
oxytocin 2 units/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefamandole 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefamandole 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vinblastine sulfate 10 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 518 mg (iodine 240 mg)/mL injection, 20 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 755 mg (iodine 350 mg)/mL injection, 125 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 388 mg (iodine 180 mg)/mL injection, 20 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 755 mg (iodine 350 mg)/mL injection, 100 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 755 mg (iodine 350 mg)/mL injection, 150 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 755 mg (iodine 350 mg)/mL injection, 175 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vincristine sulfate 1 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Ondansetron (Mylan) 8 mg/4 mL injection, 4 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ondansetron 8 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ondansetron 4 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
insulin aspart 100 units/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|